blinkx

  • Kirkland's Daniel Wolf on uniqueness of Bristol-Myers-Inhibitex

  • 00:02:18
  • Deal Video
    • Browse

Kirkland's Daniel Wolf on uniqueness of Bristol-Myers-Inhibitex

Kirkland's' Daniel Wolf tells The Deal Pipeline about his unique experience in advising Bristol-Myers Squibb in its $2.5 billion acquisition of Inhibitex.

Deal Video | June 15, 2012Watch more videos from Deal Video

Tags:. .squibb. .kirkland. .pipeline. .bristol. .acquisition











Acquisition   Advising   Billion   Bristol   Kirkland   Myers   Pipeline   Squibb   Wolf